Your browser doesn't support javascript.
loading
Digestion profile, antioxidant, and antidiabetic capacity of Morchella esculenta exopolysaccharide: in vitro, in vivo and microbiota analysis.
Wu, Haishan; Chen, Jing; Liu, Yuting; Cheng, Haoran; Nan, Jian; Park, Hyun Jin; Yang, Liu; Li, Jinglei.
Afiliación
  • Wu H; School of Food and Biological Engineering, Hefei University of Technology, Hefei, P.R. China.
  • Chen J; Teaching and Research Section of Clinical Nursing, Xiangya Hospital, Central South University, Changsha, China.
  • Liu Y; Department of Oral Mucosa, Center of Stomatology, Xiangya Hospital, Central South University, Changsha, China.
  • Cheng H; School of Food and Biological Engineering, Hefei University of Technology, Hefei, P.R. China.
  • Nan J; School of Food and Biological Engineering, Hefei University of Technology, Hefei, P.R. China.
  • Park HJ; School of Food and Biological Engineering, Hefei University of Technology, Hefei, P.R. China.
  • Yang L; School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.
  • Li J; School of Food and Biological Engineering, Hefei University of Technology, Hefei, P.R. China.
J Sci Food Agric ; 103(9): 4401-4412, 2023 Jul.
Article en En | MEDLINE | ID: mdl-36807912
ABSTRACT

BACKGROUND:

Novel functional polysaccharides from fungi are important nutraceuticals. An exopolysaccharide, Morchella esculenta exopolysaccharide (MEP 2), was extracted and purified from the fermentation liquor of M. esculenta. The aim of this study was to investigate its digestion profile, antioxidant capacity, and effect on the microbiota composition in diabetic mice.

RESULTS:

The study found that MEP 2 was stable during in vitro saliva digestion but was partially degraded during gastric digestion. The digest enzymes exerted a negligible effect on the chemical structure of MEP 2. Molecular weight and atomic force microscope (AFM) images suggest that both smaller chains and larger aggregations were produced. Scanning electron microscope (SEM) images reveal that the surface morphology was much altered after intestinal digestion. After digestion, the antioxidant ability increased as revealed by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assays. Both MEP 2 and its digested components showed strong α-amylase and moderate α-glucosidase inhibition activity, leading us to further investigate its ability to modulate the diabetic symptoms. The MEP 2 treatment ameliorated the inflammatory cell infiltration and increased the size of pancreas inlets. Serum concentration of HbA1c was significantly reduced. Blood glucose level during the oral glucose tolerance test (OGTT) was also slightly lower. The MEP 2 increased the diversity of the gut microbiota and modulated the abundance of several important bacteria including Alcaligenaceae, Caulobacteraceae, Prevotella, Brevundimonas, Demequina, and several Lachnospiraceae species.

CONCLUSION:

It was found that MEP 2 was partially degraded during in vitro digestion. Its potential antidiabetic bioactivity may be associated with its α-amylase inhibition and gut microbiome modulation ability. © 2023 Society of Chemical Industry.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Experimental / Microbiota Límite: Animals Idioma: En Revista: J Sci Food Agric Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Experimental / Microbiota Límite: Animals Idioma: En Revista: J Sci Food Agric Año: 2023 Tipo del documento: Article